ColoSTAT® Access Program
ColoSTAT® is now available through a growing network of clinics and collection centres across Australia. Join the program as a clinician.
The ColoSTAT® Access Program (CAP) is a clinician-led access initiative designed to support the responsible introduction of ColoSTAT® into symptomatic colorectal cancer (CRC) pathways.
The program enables early clinical access for selected clinicians while maintaining existing standards of care and respecting full clinical independence. Participation in the CAP includes an initial allocation of subsidised tests, followed by access on standard commercial terms unless the clinician elects to opt out.
The CAP is designed to:
• Enable early, appropriate access to ColoSTAT® for patients presenting with symptoms suggestive of CRC.
• Support clinician-led decision-making in real-world settings where diagnostic pathways may be uncertain or capacity-constrained.
• Generate high-quality, de-identified real-world evidence to complement existing clinical validation.
ColoSTAT® Access Program is not a research study or pilot.
It is a structured clinical access initiative aligned with Rhythm Biosciences’ commercial, regulatory, and evidence-generation strategy.
How to participate
Clinician Eligibility
Participation is by invitation or you can register your interests, with an initial cohort of a limited number of clinicians. Priority profiles include:
- Gastroenterologists and colorectal specialists involved in colonoscopy triage and referral prioritisation.
- Clinical leaders and key opinion leaders contributing to education, pathway development, or guideline discussions.
- General practitioners with high exposure to symptomatic CRC presentations.
Additional considerations include early-adopter mindset, geographic diversity, and willingness to provide structured feedback. If this represents you and your clinic, register below and one of our staff will make contact with you.
Register: Express your interest using the form here or contact support@rhythmbio.com.
Patient Eligibility
First speak to your doctor: Ask your GP or your specialist if ColoSTAT® is right for you. Your doctor will provide a referral first.
- Aged 45–84 years
- Presenting with symptoms associated with CRC
- Eligible for colonoscopy referral under standard clinical practice
Exclusion Criteria
- Known high-risk hereditary syndromes (e.g. Lynch syndrome, FAP)
- Inflammatory bowel disease
- Asymptomatic, low-risk individuals
- Age under 45 or over 84 years
- Current or recent chemotherapy (within 12 months)
- Unwilling to provide further details regarding follow-up colonoscopy results or other specified details of the CAP
Rhythm’s ColoSTAT® Service Details
| Detail | Information |
|---|---|
| Collection method | Standard venous blood draw (serum) |
| Collection partner | 4Cyte Pathology |
| Laboratory | Rhythm Biosciences’ NATA-accredited facility |
| Patient preparation | None — no dietary, medication, or bowel preparation required |
| Turnaround time | Results returned to clinician within 4 to 10 business days depending on samples received |
| Referral required | Yes — from the patient’s treating clinician |
Accreditation
All ColoSTAT® samples are analysed at Rhythm Biosciences’ NATA-accredited laboratory, ensuring the highest standards of quality and reliability.
Frequently Asked Questions
How do I enrol my clinic in the ColoSTAT® Access Program?
Complete the expression of interest form below, or email support@rhythmbio.com. Our team will guide you through the simple onboarding process.
Is there a cost to participate as a clinician?
There is no cost to participate in the program but does require willingness to provide structured feedback and getting patient consent.
Can patients self-refer?
No. Patients require a referral from their treating clinician (GP or specialist) to access ColoSTAT®.
Where can I find participating CAP members?
Member participation is growing every month. If you wish to access the test through our CAP members, please submit the following enquiry and our team will assist in finding the right clinician.
How are results delivered?
Results are sent to the referring clinician. Patients should follow up with their doctor to discuss their results.
HAVE A QUESTION?
